GWS Medika Conducts CME Talk to Raise Awareness about Blood Cancer

by Kristihandaribullet
Share this article
Reviewed by dr. Bandoro
GWS Medika Conducts CME Talk to Raise Awareness about Blood Cancer
GWS Medika Conducts CME Talk to Raise Awareness about Blood Cancer

GWS Medika again held a CME Talk (Continuing Medical Education) to increase knowledge and update information about blood cancer for the medical team. The CME Talk is entitled "Understanding Blood Cancer: Acute Lymphoblastic Leukemia (ALL) and Acute Myeloma Leukemia (AML), as well as Hematopoietic Stem Cell Transplantation."

The event, which took place at Plaza Timor, Jakarta Pusat, was attended by GWS Medika doctors and nurses. dr. Lee Yuh Shan, a consultant hematologist from Parkway Cancer Center (PCC) in Singapore, was present as a speaker.

He has extensive experience in hematology, particularly lymphoma and myeloma, in addition to hematopoietic stem cell transplantation and Chimeric Antigen Receptor (CAR) T-cell therapy.

Meanwhile, dr. Tanujaa Rajasekaran, senior cancer consultant from Mount Elizabeth Hospital Novena, explained that cancer screening uses blood samples and can detect 50 types of cancer. Screening results can be known 12–18 days after taking the blood sample.

Understanding blood cancer

dr. Lee explained blood cancers, specifically lymphoma and myeloma, as well as hematopoietic stem cell transplantation.

Blood cancer is a group of cancers that arises from the abnormal development of blood cells in the bone marrow, lymph nodes, or immune system. Lymphoma is a kind of blood cancer that begins from lymphocyte cells, while myeloma usually occurs in plasma cells in the bone marrow.

Hematopoietic stem cell transplantation (HSCT) is a medical procedure in which healthy blood stem cells are transplanted into a patient's body to replace damaged or abnormal blood cells. This therapy can hold promise in treating lymphoma and myeloma to produce a better response while curing the diseases.

Through a 90-minute session featuring clear explanations and interactive discussions, dr. Lee provides the GWS Medika medical team with the knowledge to deliver optimal diagnosis, treatment, and healing approaches, ultimately improving the quality of life for blood cancer patients.

It is also hoped that this scientific update will enhance diagnostic capabilities and make cancer detection easier for doctors in their regular clinical practice.

After this event, it is hoped that the medical team can increase public awareness about preventing and lowering the chance of developing blood cancer.

For example, having a healthy diet, staying active, and not smoking. Early detection through routine examinations and awareness of the early symptoms of cancer is important to ensure that people receive effective treatment that can increase their chances of recovery.

Commitment to quality health services

GWS Medika is committed to providing high-quality health services by continuing to improve the knowledge and competence of the medical team. This CME Talk is one of GWS Medika's efforts to achieve this commitment.